63-Year-Old Man With Chronic Hepatitis C Virus Infection and Proteinuria
Corlan O. Adebajo,Insara Jaffer Sathick,Vesna D. Garovic +2 more
- Vol. 88, Iss: 9
Reads0
Chats0
TLDR
A 63-year-old man presented for evaluation of right-sided abdominal pain of 2 days’ duration, which showed minimally active (grade 1) HCV without fibrosis; a human immunodeficiency virus (HIV) test done at that time yielded negative results.Abstract:
Resident in Internal Medicine, Mayo School of Graduate Medical Education, Mayo Clinic, Rochester, MN (C.O.A., I.J.S.); Adviser to residents and Consultant in Nephrology and Hypertension, Mayo Clinic, Rochester, MN (V.D.G.). A 63-year-old man presented for evaluation of right-sided abdominal pain of 2 days’ duration. He had no fever, chills, nausea, vomiting, poor oral intake, diarrhea, hematemesis, or melena. The pain did not correlate with food intake, and he did not have anorexia. He reported no dysuria, hematuria, recent travel, or herbal supplement or over-the-counter medication use, including any nonsteroidal anti-inflammatory drugs. His medical history was remarkable for chronic hepatitis C virus (HCV) genotype 2b infection, normocytic anemia, cholecystectomy, fatty liver, dyslipidemia, hypertension, and alcohol and intravenous drug abuse. He had undergone liver biopsy 9 years before the current presentation, which showed minimally active (grade 1) HCV without fibrosis; a human immunodeficiency virus (HIV) test done at that time yielded negative results. Recent esophagogastroduodenoscopy performed for evaluation of chronic dyspepsia showed changes consistent with portal hypertensive gastropathy. His medications included simvastatin, amlodipine, and thiamine. At presentation, the patient was hypertensive, alert, and oriented. He had multiple tattoos on his face, abdomen, and arms. Cardiac examination revealed normal heart sounds with no murmurs or elevated jugular venous pressure. His lungs were clear to auscultation. Although his abdomen was not distended, there was tenderness in the epigastrium and right upper and lower quadrants. Neither guarding nor rebound tenderness was noted. Bowel sounds were present, and his extremities were without edema. The remainder of the physical examination findings were unremarkable. Vital signs were as follows: pulse rate, 92 beats/min and regular; blood pressure, 162/113 mm Hg; temperature, 36.8 C; and oxygen saturation, 92% while the patient breathed room air.read more
Citations
More filters
Journal ArticleDOI
Sofosbuvir and ledipasvir decreased nephrotic syndrome caused by IgA nephropathy with a membranoproliferative pattern of injury in hepatitis C virus-induced cirrhosis: a case report
TL;DR: In this paper , a 52-year-old woman with hepatitis C virus (HCV)-induced cirrhosis had undergone splenectomy and cholecystectomy due to complications.
Journal ArticleDOI
Comparative Analysis of Adverse Drug Reactions between Interferon Alpha 2B and Sofosbuvir in the Treatment of Hepatits C at GIMHS, Sindh, Pakistan
Sajid Ali,Marvi Metlo,Zuheeb Ahmed,Tahseen Ahmed,Arslan Ahmer,Muhammad Aslam Abbassi,Saima Samtio,Syed Adeel Ahmed Shah,Sham Lal,Rashid Ali Arbani +9 more
TL;DR: This study concluded that as compared to Interferon, rate of ADR’S were less with Sofosbuvir.
References
More filters
Book
Harrison's Principles of Internal Medicine
TL;DR: In this article, Cardinal Manifestations of Disease Genetics and Disease Clinical Pharmacology Nutrition Infectious Disease Disorders Of The Cardiovascular System Disorders Of the Kidney And Urinary Tract Disorders Of Gastrointestinal System Disorders of The Immune System, Connective Tissue And Joints Hematology And Oncology Endocrinology And Metabolism Neurologic Disorders Environmental And Occupational Hazards.
Journal ArticleDOI
KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease
TL;DR: This study presents baseline characteristics of hemodialysis patients with chronic HCV infection receiving IFN-based regimens and evidence profile for treatment regimens for pegylated-interferon monotherapy and ribavirin in kidney transplant recipients with chronicHCV infection.
Journal ArticleDOI
Membranoproliferative Glomerulonephritis — A New Look at an Old Entity
TL;DR: The causes, pathogenesis, and clinical management of membranoproliferative glomerulonephritis are discussed, which accounts for 7 to 10% of biopsy-confirmed glomerUL onephritis cases.
Journal ArticleDOI
Kidney Disease: Improving Global Outcomes
TL;DR: The first three KDIGO guidelines—treatment of hepatitis C, management of bone and mineral disease, and care of kidney transplant recipients—have been finalized and the next three—acute kidney injury, Management of glomerulonephritis, and management of blood pressure in chronic kidney disease—are under development.
Journal ArticleDOI
Renal manifestations of hepatitis C virus infection
Richard J. Johnson,Richard A. Willson,Hideaki Yamabe,William G. Couser,Charles E. Alpers,Mark H. Wener,Connie L. Davis,David R. Gretch +7 more
TL;DR: Some of the more recently recognized extrahepatic manifestations of HCV infection are discussed, with particular emphasis on its association with glomerular disease.